FDA approval, atopic dermatitis study top dermatology reads for week

The FDA’s approval of Baxdela for treating acute bacterial skin and skin structure infections was among the top read articles of the past week on Healio.com/Dermatology.

Other widely-read articles included study findings that adults with atopic dermatitis had a significantly higher risk of developing certain ocular diseases compared with the general population:

FDA approves Baxdela to treat acute bacterial skin infections

The FDA announced today that it has approved Baxdela to treat acute bacterial skin and skin structure infections.

Baxdela (delafloxacin, Melinta Therapeutics) is an antibacterial drug available for intravenous and oral use, according to a news release from the FDA. Read more

Atopic dermatitis associated with ocular disease risk

Adults with atopic dermatitis had a significantly higher risk of developing conjunctivitis, keratitis and keratoconus compared with the general population, according to recently published study results in the Journal of the American Academy of Dermatology.

Researchers in Denmark used nationwide registries of all Danish adults at least 18 years of age on Jan. 1, 1997 to determine adults with atopic dermatitis (AD). Read more

Variation seen in number of stages per case of Mohs micrographic surgery

There was a marked variation in the number of stages per case of Mohs micrographic surgery of head and neck, genitalia, hands and feet skin cancers, according to study results published in JAMA Dermatology.

Researchers used Medicare Part B claims data to conduct a retrospective analysis between 2012 and 2014 of 2,305 individual billing physicians (66.8% male) who received Medicare payments for performing Mohs micrographic surgery (MMS). Read more

Platelet-rich plasma shows efficacy in combination treatment for androgenetic alopecia

Platelet-rich plasma in combination with 5% minoxidil solution showed efficacy in hair regrowth for patients with androgenetic alopecia compared with the combination with oral finasteride, according to study results recently published in Dermatologic Surgery.

Researchers studied 25 patients with androgenetic alopecia (13 females; mean age, 39.9 years). Read more

Patients with psoriasis experience cardiometabolic comorbidities

Patients with psoriasis have a prevalence of certain comorbidities that contribute to metabolic syndrome, according to recently published study results in the Journal of the American Academy of Dermatology.

Researchers used the Truven Health Analytics MarketScan database, which includes claims for commercially insured U.S. patients, to measure the extent of comorbidities in patients with psoriasis. Read more